Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Screening for Chlamydia trachomatis (CT) with routine Pap smears in general practice: a randomized controlled trial
ISRCTN ISRCTN16261241
ClinicalTrials.gov identifier
Public title Screening for Chlamydia trachomatis (CT) with routine Pap smears in general practice: a randomized controlled trial
Scientific title
Acronym GPPaCTS
Serial number at source 268058
Study hypothesis General practices randomized to CT/Pap screening for women aged 16 to 39 years (intervention) will have an increased participation rate for chlamydia screening compared to those practices randomised to offer 'usual care' (control).
Lay summary
Ethics approval Added as of 30/07/2007:
This study was approved by:
1. The ACT Health Human Research Ethics Committee (ETH.10/03)
2. The Australian National University Ethics Committee (ref: 2003/270)
Study design Randomised controlled trial
Countries of recruitment Australia
Disease/condition/study domain Chlamydia trachomatis
Participants - inclusion criteria Women between the ages of 16 and 39 years who have ever been sexually active and who present to their general practitioner.
Participants - exclusion criteria Women who have never been sexually active.
Anticipated start date 01/11/2004
Anticipated end date 01/03/2006
Status of trial Completed
Patient information material
Target number of participants 1440
Interventions Routine offering of testing for Chlamydia trachomatis at the time of regular Pap smear versus usual care.
Primary outcome measure(s) Participation rates in screening for Chlamydia trachomatis.
Secondary outcome measure(s) Uptake of Pap smears in women in target age range.
Sources of funding Australian National Health and Medical Research Council: 268058
Trial website
Publications
Contact name Prof  Francis  Bowden
  Address The Canberra Hospital
P.O. Box 11
  City/town Woden
  Zip/Postcode 2606
  Country Australia
  Tel +61 (0)2 6244 2063
  Fax +61 (0)2 6232 4037
  Email frank.bowden@act.gov.au
Sponsor Australian National Health and Medical Research Council
  Address Office of NHMRC (MDP 100)
GPO Box 9848
  City/town Canberra
  Zip/Postcode 2601
  Country Australia
  Tel +61 (0)2 6289 1555
  Fax +61 (0)2 6289 9132
  Email research@nhmrc.gov.au
  Sponsor website: http://www.nhmrc.gov.au/
Date applied 09/09/2005
Last edited 30/07/2007
Date ISRCTN assigned 31/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central